3 ETFs Likely to Hold SpaceX

How and when these index ETFs will add Mega-IPOs. What Happens If Tesla and SpaceX Merge?

Morningstar • Jun 11, 2026

Rosenbluth Discusses ETF Implications of the SpaceX IPO on Yahoo! Finance

VettaFi Head of Research Todd Rosenbluth appeared on Yahoo! Finance to discuss the implications of the highly anticipated SpaceX IPO on the ETF market.

ETF Trends • Jun 10, 2026

Should iShares Russell 1000 ETF (IWB) Be on Your Investing Radar?

The iShares Russell 1000 ETF (IWB) was launched on May 15, 2000, and is a passively managed exchange traded fund designed to offer broad exposure to the Large Cap Blend segment of the US equity market.

Zacks Investment Research • Jun 1, 2026

Dual Commencement: The Russell Index Shift to Semi-Annual Rebalancing

June is typically reserved for graduation processionals, with the “Pomp and Circumstance March No. 1 in D” blaring from PA systems or high-fidelity systems (depending on how well-funded the school is).

ETF Trends • Apr 29, 2026

Russell U.S. Indexes Spotlight - Quarterly Report: April 2026

The Middle East crisis led to a broad selloff in Russell equity segments in March halting the year-long rally. 12M forward P/Es derated broadly but more so for Russell 1000, Top 200 and the large- and small-cap Growth indices partly due to their heavy Tech exposure and valuation expansion over the last three years.

Seeking Alpha • Apr 20, 2026

IWB: High Multiple Means High Sensitivity To Reinflation Risk

The iShares Russell 1000 ETF offers broad U.S. market exposure but is nearly identical to IVV with a tech-heavy allocation but higher expenses. Rising capital costs associated with heightened geopolitical uncertainty, especially from ongoing Middle East conflicts, are a major risk to high-multiple stocks. High multiples in IWB's megacap tech holdings are vulnerable to rising discount rates.

Seeking Alpha • Mar 30, 2026

Polen Focus Growth Portfolio  Q4 2025 Performance, Attribution & Portfolio Activity

Eli Lilly's stock price has underperformed this year, much of it on the back of drug pricing concerns, potential tariff impacts and, perhaps, less enthusiasm for GLP-1 drugs. The primary drag for the quarter was Oracle, accounting for almost all of the Portfolio's relative underperformance in Q4, completely reversing its performance from the prior quarter and giving back all of the gains experienced in Q3. Polen Capital initiated a 2.25% position in Intuitive Surgical who maintain a de facto monopoly in soft tissue robotic surgery globally.

Seeking Alpha • Jan 21, 2026

Decoding the Bull Case for Small Caps

There's a lot of buzz about the opportunity in US small cap stocks this year. There's a confluence of factors that seem aligned just right for the segment, chief amongst them earnings growth expectations.

ETF Trends • Jan 16, 2026

Are Small-Caps Worth a Steak Dinner?

Coming into 2025, amid a debate about concentration and lofty valuations in the largest of large-cap stocks, as well as concerns about macro uncertainty and economic conditions, we collectively called for diversification. That diversification, among other things, singled out the opportunity in small-caps.

ETF Trends • Dec 17, 2025

IWB: Current Risks And Market Valuation Are A Problem

IWB mirrors the broad US market, with tech-heavy exposure and no unique drivers, making it sensitive to macroeconomic trends. Fed policy remains cautious and data-dependent, with rate cuts unlikely before September, contributing to ongoing market uncertainty. Trade tensions, geopolitical risks, and recent fund outflows point to heightened volatility and weak market sentiment for IWB.

Seeking Alpha • May 28, 2025